| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aims+Scope/Editorial Board/Publication information
|
|
|
|
184 |
C |
p.
|
artikel
|
| 2 |
A perspective on in person scientific meetings
|
Lefresne, Shilo
|
|
|
184 |
C |
p.
|
artikel
|
| 3 |
A pulmonary vein atlas for radiotherapy planning
|
Walls, Gerard M
|
|
|
184 |
C |
p.
|
artikel
|
| 4 |
Are hybrid conferences the new standard?
|
Baumann, Michael
|
|
|
184 |
C |
p.
|
artikel
|
| 5 |
A subregion-based prediction model for local–regional recurrence risk in head and neck squamous cell carcinoma
|
Pan, Ziqi
|
|
|
184 |
C |
p.
|
artikel
|
| 6 |
CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T
|
von Knebel Doeberitz, Nikolaus
|
|
|
184 |
C |
p.
|
artikel
|
| 7 |
Comparison the acute toxicity of two different induction chemotherapy schedules with cisplatin and fluorouracil in nasopharyngeal carcinoma patients
|
Zong, Jing Feng
|
|
|
184 |
C |
p.
|
artikel
|
| 8 |
Comprehensive dose evaluation of a Deep Learning based synthetic Computed Tomography algorithm for pelvic Magnetic Resonance-only radiotherapy
|
Wyatt, Jonathan J
|
|
|
184 |
C |
p.
|
artikel
|
| 9 |
Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy
|
Peters, Nils
|
|
|
184 |
C |
p.
|
artikel
|
| 10 |
Contents
|
|
|
|
184 |
C |
p.
|
artikel
|
| 11 |
Corrigendum to “Master protocol trial design for technical feasibility of MR-guided radiotherapy” [Radiother. Oncol. 166 (2022) 33–36]
|
Couwenberg, Alice
|
|
|
184 |
C |
p.
|
artikel
|
| 12 |
Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients
|
Zhao, Da-wei
|
|
|
184 |
C |
p.
|
artikel
|
| 13 |
Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
|
Jaspers, Jaap P.M.
|
|
|
184 |
C |
p.
|
artikel
|
| 14 |
EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study
|
Peng, Ping
|
|
|
184 |
C |
p.
|
artikel
|
| 15 |
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
|
Cibula, David
|
|
|
184 |
C |
p.
|
artikel
|
| 16 |
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma
|
Niyazi, Maximilian
|
|
|
184 |
C |
p.
|
artikel
|
| 17 |
Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation
|
Wang, Youke
|
|
|
184 |
C |
p.
|
artikel
|
| 18 |
High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: A systematic review and meta-analysis
|
Yao, Yuanhu
|
|
|
184 |
C |
p.
|
artikel
|
| 19 |
Implementation and evaluation of an intelligent automatic treatment planning robot for prostate cancer stereotactic body radiation therapy
|
Gao, Yin
|
|
|
184 |
C |
p.
|
artikel
|
| 20 |
Mechanisms of the ‘FLASH’ effect: Radiation chemistry should not be ignored in developing models
|
Wardman, Peter
|
|
|
184 |
C |
p.
|
artikel
|
| 21 |
No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis
|
Kim, Byoung Hyuck
|
|
|
184 |
C |
p.
|
artikel
|
| 22 |
Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials
|
Saifi, Omran
|
|
|
184 |
C |
p.
|
artikel
|
| 23 |
Pre-operative stereotactic radiosurgery for cerebral metastatic disease: A retrospective dose-volume study
|
Bugarini, Alejandro
|
|
|
184 |
C |
p.
|
artikel
|
| 24 |
Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles
|
Lin, Peter
|
|
|
184 |
C |
p.
|
artikel
|
| 25 |
Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model based clinic
|
de Jong, Bas A.
|
|
|
184 |
C |
p.
|
artikel
|
| 26 |
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
|
Zhao, Wensi
|
|
|
184 |
C |
p.
|
artikel
|
| 27 |
Repeat stereotactic body radiotherapy for oligometastatic disease
|
Willmann, Jonas
|
|
|
184 |
C |
p.
|
artikel
|
| 28 |
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study
|
Corkum, Mark T.
|
|
|
184 |
C |
p.
|
artikel
|
| 29 |
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
|
Scharl, Sophia
|
|
|
184 |
C |
p.
|
artikel
|
| 30 |
The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients
|
Onal, Cem
|
|
|
184 |
C |
p.
|
artikel
|
| 31 |
The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy
|
Fiagan, Yawo A.C.
|
|
|
184 |
C |
p.
|
artikel
|
Tijdschrift beschrijving